167 related articles for article (PubMed ID: 24921676)
1. Serotonin noradrenaline reuptake inhibitors: Logical evolution of antidepressant development.
Montgomery S
Int J Psychiatry Clin Pract; 2006; 10 Suppl 2():5-11. PubMed ID: 24921676
[TBL] [Abstract][Full Text] [Related]
2. Serotonin and Norepinephrine Reuptake Inhibitors.
Shelton RC
Handb Exp Pharmacol; 2019; 250():145-180. PubMed ID: 30838456
[TBL] [Abstract][Full Text] [Related]
3. Dual serotonin and noradrenaline reuptake inhibitors: Focus on their differences.
Blier P
Int J Psychiatry Clin Pract; 2006; 10 Suppl 2():22-32. PubMed ID: 24921679
[TBL] [Abstract][Full Text] [Related]
4. Milnacipran: a unique antidepressant?
Kasper S; Pail G
Neuropsychiatr Dis Treat; 2010 Sep; 6(Suppl I):23-31. PubMed ID: 20856597
[TBL] [Abstract][Full Text] [Related]
5. SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants.
Stahl SM; Grady MM; Moret C; Briley M
CNS Spectr; 2005 Sep; 10(9):732-47. PubMed ID: 16142213
[TBL] [Abstract][Full Text] [Related]
6. [Serotonin-noradrenaline reuptake inhibitors(SNRIs)].
Ishigooka J
Nihon Rinsho; 2001 Aug; 59(8):1523-9. PubMed ID: 11519152
[TBL] [Abstract][Full Text] [Related]
7. Venlafaxine:a novel antidepressant compound.
Schweizer E; Thielen RJ; Frazer A
Expert Opin Investig Drugs; 1997 Jan; 6(1):65-78. PubMed ID: 15989562
[TBL] [Abstract][Full Text] [Related]
8. Serotonin noradrenaline reuptake inhibitors: A new generation of treatment for anxiety disorders.
Baldwin DS
Int J Psychiatry Clin Pract; 2006; 10 Suppl 2():12-5. PubMed ID: 24921677
[TBL] [Abstract][Full Text] [Related]
9. Brain region-specific effects of short-term treatment with duloxetine, venlafaxine, milnacipran and sertraline on monoamine metabolism in rats.
Muneoka K; Shirayama Y; Takigawa M; Shioda S
Neurochem Res; 2009 Mar; 34(3):542-55. PubMed ID: 18751896
[TBL] [Abstract][Full Text] [Related]
10. Milnacipran: serotonin-noradrenaline reuptake inhibitor approved for fibromyalgia may be a useful antidepressant.
Keks NA; Hope J; Keogh S; Copolov DL
Australas Psychiatry; 2018 Oct; 26(5):537-540. PubMed ID: 30198305
[TBL] [Abstract][Full Text] [Related]
11. Levomilnacipran (F2695), a norepinephrine-preferring SNRI: profile in vitro and in models of depression and anxiety.
Auclair AL; Martel JC; Assié MB; Bardin L; Heusler P; Cussac D; Marien M; Newman-Tancredi A; O'Connor JA; Depoortère R
Neuropharmacology; 2013 Jul; 70():338-47. PubMed ID: 23499664
[TBL] [Abstract][Full Text] [Related]
12. Dual serotonin and noradrenaline uptake inhibitor class of antidepressants potential for greater efficacy or just hype?
Wong DT; Bymaster FP
Prog Drug Res; 2002; 58():169-222. PubMed ID: 12079200
[TBL] [Abstract][Full Text] [Related]
13. Milnacipran, a new serotonin and noradrenaline reuptake inhibitor: an overview of its antidepressant activity and clinical tolerability.
Puech A; Montgomery SA; Prost JF; Solles A; Briley M
Int Clin Psychopharmacol; 1997 Mar; 12(2):99-108. PubMed ID: 9219045
[TBL] [Abstract][Full Text] [Related]
14. Milnacipran, a new specific serotonin and noradrenaline reuptake inhibitor.
Boyer P; Briley M
Drugs Today (Barc); 1998 Aug; 34(8):709-20. PubMed ID: 14988777
[TBL] [Abstract][Full Text] [Related]
15. The Role of Metabolites of Antidepressants in the Treatment of Depression.
Rudorfer MV; Potter WZ
CNS Drugs; 1997 Apr; 7(4):273-312. PubMed ID: 27520753
[TBL] [Abstract][Full Text] [Related]
16. Japanese experience with milnacipran, the first serotonin and norepinephrine reuptake inhibitor in Japan.
Higuchi T; Briley M
Neuropsychiatr Dis Treat; 2007 Feb; 3(1):41-58. PubMed ID: 19300537
[TBL] [Abstract][Full Text] [Related]
17. Tolerability of serotonin norepinephrine reuptake inhibitor antidepressants.
Montgomery SA
CNS Spectr; 2008 Jul; 13(7 Suppl 11):27-33. PubMed ID: 18622372
[TBL] [Abstract][Full Text] [Related]
18. Optimizing antidepressant treatment: efficacy and tolerability.
Deakin B; Dursun S
Int Clin Psychopharmacol; 2002 Jun; 17 Suppl 1():S13-24. PubMed ID: 12369607
[TBL] [Abstract][Full Text] [Related]
19. Serotonin noradrenaline reuptake inhibitors: New hope for the treatment of chronic pain.
Delgado PL
Int J Psychiatry Clin Pract; 2006; 10 Suppl 2():16-21. PubMed ID: 24921678
[TBL] [Abstract][Full Text] [Related]
20. Milnacipran: an antidepressant with dual selectivity of action on noradrenaline and serotonin uptake.
Delini-Stula A
Hum Psychopharmacol; 2000 Jun; 15(4):255-260. PubMed ID: 12404320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
